Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
Revenue
Product sales	$ 200,000	$ 316,000	$ 207,950	$ 537,080
Cost of product sales	45,943	98,148	48,240	168,366
Gross profit from product sales	154,057	217,852	159,710	368,714
Other Revenue
Retained royalties	2,256	2,348	4,648	4,952
Other income	17,026	13,653	25,533	17,474
Total other revenue	19,282	16,001	30,181	22,426
Operating expenses
Selling expenses	43,104	66,032	44,340	138,026
Personnel and consulting expenses	366,901	424,121	874,379	819,144
General and administrative expenses	326,522	317,305	650,161	511,026
Total operating expenses	736,527	807,458	1,568,880	1,468,196
Operating loss	(563,188)	(573,605)	(1,378,989)	(1,077,056)
Other expense
Interest expense	$ 204,669	112,895	$ 390,531	217,681
Interest expense - accelerated upon conversion of OID notes		$ 35,109		35,109
Loss on settlement of note and warrant				132,301
Loss on conversion of notes		$ 43,288	$ 2,588	43,288
Unrealized loss on derivative instruments	$ 10,903	25,952	10,903	11,720
Total other expense	215,572	217,244	404,022	440,099
Loss before income taxes	$ (778,760)	$ (790,849)	$ (1,783,011)	$ (1,517,155)
Provision (benefit) for income taxes
Net loss	$ (778,760)	$ (790,849)	$ (1,783,011)	$ (1,517,155)
Basic and diluted loss per share	$ (0.03)	$ (0.03)	$ (0.07)	$ (0.07)
Basic and diluted weighted average number of common shares outstanding:	27,862,908	23,082,699	27,318,467	21,567,885